Optimization via specific fluorescence brightness of a receptor-targeted probe for optical imaging and positron emission tomography of sentinel lymph nodes

Journal of Biomedical Optics

Volumn 18, Issue 10, 2013, Pages

  Qin, Zhengtao ^a,b,c,d   Hall, David J ^b,c,d   Liss, Michael A ^b,e   Hoh, Carl K ^b,c,d   Kane, Christopher J ^b,e   Wallace, Anne M ^b,e   Vera, David R ^b,c,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

sentinel lymph node specific fluorescence brightness fluorescence imaging positron emission tomography imaging multimodality, IRDye 800CW, 800CW tilmanocept, tilmanocept

Indexed keywords

FLUORESCENCE IMAGING; FLUORESCENCE INTENSITY MEASUREMENT; FLUORESCENT MOLECULES; MOLAR ABSORPTIVITY; OPTICAL IMAGING SYSTEM; POSITRON EMISSION TOMOGRAPHY (PET); SENTINEL LYMPH NODES; TOMOGRAPHY IMAGING;

BODY FLUIDS; COMPUTERIZED TOMOGRAPHY; FLUORESCENCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPTICAL IMAGE STORAGE; OPTIMIZATION; POSITRON EMISSION TOMOGRAPHY; PROBES; QUANTUM YIELD;

LUMINANCE;

DEXTRAN; FLUORESCENT DYE; GALLIUM-DIETHYLENETRIAMINEPENTAACETIC ACID-MANNOSYL-DEXTRAN; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GALLIUM DIETHYLENETRIAMINEPENTAACETIC ACID MANNOSYL DEXTRAN;

ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; FEMALE; FLUORESCENCE IMAGING; LYMPH NODE; METABOLISM; MOLECULAR IMAGING; MOUSE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY; ARTICLE; METHODOLOGY;

ANIMALS; DEXTRANS; FEMALE; FLUORESCENT DYES; LYMPH NODES; MICE; MOLECULAR IMAGING; OPTICAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M PENTETATE;

EID: 84886791792     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.18.10.101315     Document Type: Article

References (40)

1. R. M. Cabanas, "An approach for the treatment of penile carcinoma, " Cancer 39(2), 491-499 (1977).
2. D. L. Morton et al., "Technical details of intraoperative lymphatic mapping for early stage melanoma, " Arch. Surg. 127(4), 392-399 (1992).
3. J. C. Alex and D. N. Krag, "Gamma-probe guided localization of lymph nodes, " Surg. Oncol. 2(3), 137-143 (1993). (Pubitemid 23255936)
4. J. J. Albertini et al., "Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma, " Ann. Surg. 223(2), 217-224 (1996). (Pubitemid 26065217)
5. M. B. Faries and D. L. Morton, "Surgery and sentinel lymph node biopsy, " Semin. Oncol. 34(6), 498-508 (2007). (Pubitemid 350236309)
6. D. L. Morton et al. "Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial, " Ann. Surg. 242(3), 302-311; discussion 311-303 (2005).
7. 99mTc-diethylenetriaminepentaacetic acid-manno-syl-dextran, " in Molecular Imaging and Contrast Agent Database, National Center for Biotechnology Information, Bethesda, MD (2011).
8. 99mTc]DTPA-mannosyl-dextran, " J. Nucl. Med. 42(6), 951-959 (2001). (Pubitemid 32537445)
9. 99mTc]tilmanocept: a synthetic receptor-targeted molecule for sentinel lymph node mapping, " in Radiopharmaceuticals for Sentinel Lymph Node Detection, International Atomic Energy Agency, Vienna (in press).
10. A. M. Wallace et al., "Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping, " Ann. Surg. Oncol. 14(2), 913-921 (2007). (Pubitemid 46175343)
11. A. M. Wallace et al., "Lymphoseek: a molecular radiopharmceutical for sentinel node detection, " Ann. Surg. Oncol. 10(5), 531-538 (2003). (Pubitemid 40486916)
12. 99mTc] tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer, " Ann. Surg. Oncol. 18(4), 961-969 (2011).
13. 99mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma, " Ann. Surg. Oncol. 20(2), 680-688 (2013).
14. 99mTc]tilmanocept for sentinel lymph node mapping in breast cancer patients: result of two phase 3 trials, " Ann. Surg. Oncol. 20(8), 2590-2599 (2013).
15. 99mTc-tilmanocept approval, " J. Nucl. Med. 54(5), 20N (2013).
16. H. G. van der Poel et al., "Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodel tracer, " Eur. Urol. 60(4), 826-833 (2011).
17. 99mTc- nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT, " J. Nucl. Med. 53(7), 1034-1040 (2012).
18. I. J. Fox et al., "A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation, " Proc. Staff Meet. Mayo Clin. 32(18), 478-484 (1957)
19. Summary of Product Characteristics for Nanocoll, Kit for Radiopharmaceutical Preparation, GE Healthcare S.R.L., Milan, Italy (2009).
20. S. E. Strand and B. R. R. Persson, "Quantitative lymphoscintigraphy I: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits, " J. Nucl. Med. 20(10), 1038-1046 (1979). (Pubitemid 10241202)
21. S. P. Stroup et al., "Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in a dog model, " Clin. Exp. Metastasis 29(7), 673-680 (2012).
22. R. Tinget al., "FastF-18 labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes, " Bioconjug. Chem. 21(10), 1811-1819 (2010).
23. D. K. Emerson et al., "A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging, " Radiology 265(1), 186-193 (2012).
24. D. R. Vera et al., "Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry, " Nucl. Med. Biol. 32(7), 687-693 (2005). (Pubitemid 41502973)
25. J. L. Oncley, "Interpretation of data obtained in studies with isotope-labeled proteins of biological significance; chemical considerations, " Fed. Proc. 16(suppl 2), 3-6 (1957).
26. C. F Meares and D. A. Goodwin, "Linking radiometals to proteins with bifunctional chelating agents, " J. Protein Chem. 3(2), 215-228 (1984). (Pubitemid 14046605)
27. A. T. R. Williams, S. A. Winfield, and J. N. Miller, "Relative fluorescence quantum yields using a computer-controlled luminescence spectrometer, " Analyst 108(1290), 1067-1071 (1983).
28. P. R. Bevington, "Propagation of errors, " in Data Reduction and Error Analysis for the Physical Sciences, pp. 56-65, McGraw-Hill, Dubuque, Iowa (2003).
29. D. R. Vera, E. S. Woodle, and R. C. Stadalnik, "Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m-galactosyl-neo- glycoalbumin, " J. Nucl. Med. 30(9), 1519-1530 (1989). (Pubitemid 19231119)
30. W. C. Eckelman, M. Bonardi, and W. A. Volkert, "True radiotracers: are we approaching theoretical specific activity with Tc-99m and I-123?, " Nucl. Med. Biol. 35(5), 523-527 (2008). (Pubitemid 351858610)
31. A. Azhdarinia et al., "Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide, " Bioorgan. Med. Chem. 19(12), 3769-3776 (2011).
32. H. S. Choietal., "Synthesis and in vivo fate of zwitterionic near-infrared fluorophores, " Angew. Chem. Int. Edit. 50(28), 6258-6263 (2011).
33. D. Toptygin, "Effects of the solvent refractive index and its dispersion on the radioactive decay rate and extinction coefficient of a fluorescent solute, " J. Fluoresc. 13(3), 201-219 (2003).
34. A. Mishra et al., "Cyanines during the 1990s: a review, " Chem. Rev. 100(6), 1973-2011 (2000).
35. G. G. Guilbalt, "General aspects of luminescence spectroscopy, " in Practical Fluorescence, pp. 30-32, Marcel Dekker Inc., New York (1990).
36. H. J. Gruber et al., "Anomalous fluorescence enhancement of Cy3 and Cy3.5 versus anomalous fluorescence loss of Cy5 and Cy7 upon cova-lent linking to IgG and noncovalent binding to avidin, " Bioconjug. Chem. 11(5), 696-704 (2000).
37. A. M. Basedow and K. H. Ebert, "Production, characterization, and solution properties of dextran fractions of narrow molecualar weight distributions, " J. Polym. Sci. Pol. Sym. 66(1), 101-115 (1979).
38. M. Keramidas et al., "Intraoperative near-infrared image-guided surgery for peritoneal carcinomatosis in a preclinical experimental model, " Br. J. Surg. 97(5), 737-743 (2010).
39. Y. Kawaguchi et al., "Hepatobiliary surgery guided by a novel fluorescent imaging technique for visualizing hepatic arteries, bile ducts, and liver cancers on color images, " J. Am. Coll. Surgeons 212(6), E33-E39 (2011).
40. B. N. Breyer et al., "Pelvic lymphadenectomy in prostate cancer, " Prostate Cancer P. D. 11(4), 320-324 (2008).